Mariner Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-63,240
Closed -$52K 117
2016
Q2
$52K Hold
63,240
0.02% 124
2016
Q1
$10K Hold
63,240
﹤0.01% 164
2015
Q4
$50K Buy
+63,240
New +$1.99M 0.01% 178
2014
Q4
Sell
-110,881
Closed -$25K 282
2014
Q3
$25K Buy
+110,881
New +$3.11M 0.01% 216
2014
Q1
Sell
-36,890
Closed -$52K 323
2013
Q4
$52K Buy
+36,890
New +$1.07M 0.01% 276

Other funds holding PFE

Mariner Investment Group's PFE Position: Q2 2016 in Review

Mariner Investment Group sold out of Pfizer (PFE) in Q2 2016, closing a stake of 181,815 shares — an estimated $5.8M sold.

Mariner Investment Group first reported a position in PFE in Q1 2014 and held it in 9 quarters. The position peaked at $5.11M in Q1 2016. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Mariner Investment Group reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Mariner Investment Group sold 181,815 Pfizer shares in Q2 2016, an estimated $5.8M.
  • Mariner Investment Group first reported a position in Pfizer in Q1 2014 and held it in 9 quarters.
  • Mariner Investment Group's Pfizer position peaked at $5.11M in Q1 2016.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.